Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

5.79
Delayed Data
As of Mar 27
 +0.08 / +1.40%
Today’s Change
3.10
Today|||52-Week Range
7.84
-23.41%
Year-to-Date

Today’s Trading

Previous close5.71
Today’s open5.74
Day’s range5.61 - 5.99
Volume997,152
Average volume (3 months)871,842
Market cap$403.2M
Dividend yield--
Data as of 3:59pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-816.67%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)+464.45%
P/E ratio89.6
Price/Sales11.62
Price/Book--

Competitors

 Today’s
change
Today’s
% change
IDRAIdera Pharmaceutical...-0.07-1.86%
SPPISpectrum Pharmaceuti...+0.05+0.92%
IMDZImmune Design Corp-1.56-6.08%
AMPEAmpio Pharmaceutical...+0.22+2.89%
Data as of 4:02pm ET, 03/27/2015

Financials

Next reporting dateMay 8, 2015
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$44.4M
Annual profit (last year)$4.4M
Net profit margin9.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark Robert Baker
Chief Financial Officer, Treasurer, CAO &
VP
Angelo William Lovallo
Corporate headquarters
Tarrytown, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account